Hemophilia B

Disease State Hub

News
Research Summaries
Resources
FDA Alerts Pearls of Wisdom From the Journal
Insights
Commentary Podcasts Q&As Videos
Interactive
Polls Quizzes Slideshows
Events & Education

FDA Alerts

Lung cancer
Lung cancer
FDA Approves Tagrisso for Non-Small Cell Lung Cancer
03/31/2017
The FDA approved osimertinib for the treatment of patients with metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer.
03/31/2017
Multiple Sclerosis
Multiple Sclerosis
FDA Approves Ocrevus for the Treatment of Multiple Sclerosis
03/29/2017
The FDA approved Ocrevus for the treatment of relapsing forms of multiple sclerosis and primary progressive multiple sclerosis in adult patients.
03/29/2017
Multiple Sclerosis
Multiple Sclerosis
FDA Approves Ocrevus for the Treatment of Multiple Sclerosis
03/29/2017
The FDA approved Ocrevus for the treatment of relapsing forms of multiple sclerosis and primary progressive multiple sclerosis in adult patients.
03/29/2017
Multiple Sclerosis
Multiple Sclerosis
FDA Approves Ocrevus for the Treatment of Multiple Sclerosis
03/29/2017
The FDA approved Ocrevus for the treatment of relapsing forms of multiple sclerosis and primary progressive multiple sclerosis in adult patients.
03/29/2017
Eczema
Eczema
FDA: Dupixent Approved for the Treatment of Eczema
03/28/2017
The US Food and Drug Administration has approved Dupixent for the treatment of moderate-to-severe eczema in adults.
03/28/2017
Eczema
Eczema
FDA: Dupixent Approved for the Treatment of Eczema
03/28/2017
The US Food and Drug Administration has approved Dupixent for the treatment of moderate-to-severe eczema in adults.
03/28/2017
Eczema
Eczema
FDA: Dupixent Approved for the Treatment of Eczema
03/28/2017
The US Food and Drug Administration has approved Dupixent for the treatment of moderate-to-severe eczema in adults.
03/28/2017
FDA ALERT
fda
FDA ALERT
FDA Approves Bavencio for Merkel Cell Carcinoma
03/23/2017
The FDA granted accelerated approval to Bavencio (avelumab) for the treatment of adult and pediatric patients with metastatic Merkel cell carcinoma.
03/23/2017
FDA ALERT
fda
FDA ALERT
FDA Approves Bavencio for Merkel Cell Carcinoma
03/23/2017
The FDA granted accelerated approval to Bavencio (avelumab) for the treatment of adult and pediatric patients with metastatic Merkel cell carcinoma.
03/23/2017
Parkinson Disease
Parkinson Disease
FDA Approves Add-On Treatment for Parkinson Disease
03/21/2017
The FDA has approved Xadago, an add-on treatment for patients with Parkinson disease who experience “off” episodes.
03/21/2017